Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2009 | 03-2009 | |
| Sales | 13,591 | 13,092 |
| Cost of Goods | 6,040 | 5,839 |
| Gross Profit | 7,551 | 7,252 |
| Operating Expenses | 7,655 | 8,403 |
| Operating Income | -64 | -311 |
| Interest Expense | 563 | 543 |
| Other Income | -169 | 40 |
| Pre-tax Income | -796 | -815 |
| Income Tax | 56 | 64 |
| Net Income Continuous | -852 | -879 |
| Net Income | $-852 | $-879 |
| EPS Basic Total Ops | N/A | -0.12 |
| EPS Basic Continuous Ops | N/A | -0.06 |
| EPS Diluted Total Ops | N/A | -0.12 |
| EPS Diluted Continuous Ops | N/A | -0.06 |
| EBITDA(a) | $896 | $617 |